ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,146.86
-0.21%
Dow Jones
38,589.16
-0.15%
Gold vs US Dollar
2,333.015
0.00%
Brent Oil
82.275
0.00%
Bitcoin
66,442.64
0.38%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Vanda Pharmaceuticals Inc (VNDA) Share Price

VNDA Vanda Pharmaceuticals Inc

6.25
-0.25 (-3.85%)
15 Jun 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Vanda Pharmaceuticals Inc NASDAQ:VNDA NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   -0.25 -3.85 6.25 5.95 6.99 6.67 6.23 6.46 1,134,894 04:00:08   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 192.64M 2.51M 0.0436 143.35 359.61M
 Type  Size  Price  Time  Units 
 20 500 6.25 23:21:07 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore VNDA News
13/06/202421:38EDGAR2Form 8-K - Current report
13/06/202415:02PRNUSVanda Pharmaceuticals Confirms Receipt of Revised Unsolicited Takeover Proposal from Future Pak
06/06/202421:30EDGAR2Form 8-K - Current report
06/06/202414:24PRNUSVanda Pharmaceuticals Confirms Receipt of Unsolicited, Non-Binding Indication of Interest from Cycle Group Holdings Ltd.
30/05/202422:20PRNUSVanda Pharmaceuticals Announces Participation in the Jefferies 2024 Global Healthcare Conference
30/05/202421:48PRNUSVanda Pharmaceuticals Announces Completion of Transfer of FDA Marketing Authorization for PONVORY®
29/05/202419:17PRNUSVanda Pharmaceuticals Announces Presentations at SLEEP 2024
Period
Draw mode
Data Downloads for VNDA

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Vanda Pharmaceuticals Inc Articles